The Aperlena Verdict
Open raceNo supplier dominates: 132 different companies have won the last 298 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- -53.2%
- Expected final price vs the published estimate
Based on 298 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryA Czech public tender covering recurring supplies of medicinal products containing the active substance human fibrinogen, meeting the requirements of the Czech medicinal products authority SUKL. The procurement is divided into parts covering fibrinogen for prophylaxis and treatment of bleeding in acquired hypofibrinogenemia (liver damage, disseminated intravascular coagulation, hyperfibrinolysis, blood loss), uncontrolled bleeding during surgery, congenital dysfibrinogenemia, and congenital hypo- or afibrinogenemia. The contracting authority is in the Czech Republic. The estimated value, the submission deadline and the detailed procurement procedure are not stated in the available information. Suppliers of medicinal products registered with SUKL requirements are the target group.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago
More from this buyer
Full buyer profile44 open tenders right now
- Czech Republic - Antineoplastic and immunomodulating agents - INTERFERON BETA-1A 2026 1 day left
- Antivirals for systemic use - LP containing letermovir 2026 2 days left
- Czech Republic - Construction modifications of healthcare facilities - Building works for buildings H1 and H2 2 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Alliance Healthcare s.r.o. | 28 | €17.6M | Aug 2026 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 26 | €17.9M | Aug 2026 |
| PHARMOS, a.s. | 12 | €4.9M | Jun 2026 |
| PROMEDICA PRAHA GROUP, a.s. | 11 | €3.9M | Aug 2026 |
| Boston Scientific Česká republika s.r.o. | 10 | €3.5M | Aug 2026 |
Based on 298 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 301 comparable contracts this buyer awarded in this sector over the last 4 years.
- €83,421
- Lower quartile
- €185,877
- Median award
- €589,945
- Upper quartile
This tender is estimated 1569% above that median
Most recent awards
- Česko - Antineoplastika - LP s obsahem pirtobrutinibu 2026 €644,580
- Česko - Antineoplastika - LP s obsahem izatuximabu 2026 €1,953,942
- Česko - Chirurgické implantáty - Implantát k léčbě prolapsu pánevního dna €60,694
- Česko - Katétry - Katétr CVC 5 lumen antibakteriální vč. setu rouškovacího €50,852
- Česko - Anestetika - LP s obsahem fentanylu 2026 II. €454,249
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€119,738
est. value
1
day left
€12,421
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,941,267
- Buyer track record on Aperlena
- 766 notices tracked · 403 awarded
- €677,106,842 in awarded contracts
Never miss a tender like this
163 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert